Sep 21, 2015 - Cymabay Therapeutics, Inc. (CBAY) was a big mover last session, as the company saw its shares rise over 7% on the day.
Sep 16, 2015 - AxoGen, Inc. (AXGN) was a big mover last session, as the company saw its shares rise almost 14% on the day.
Sep 15, 2015 - AbbVie (ABBV) is looking to get Imbruvica approved in the U.S. for the front-line treatment of patients suffering from chronic lymphocytic leukemia.
Sep 14, 2015 - Sanofi (SNY) reported positive top-line data from the second of two pivotal phase III studies (LixiLan-L) on type II diabetes candidate, LixiLan.
Sep 11, 2015 - AbbVie (ABBV) gained ninth FDA approval for Humira for the treatment of patients suffering from moderate-to-severe hidradenitis suppurativa.
Sep 11, 2015 - Relypsa, Inc. (RLYP) was a big mover last session, as the company saw its shares rise almost 8% on the day.
Sep 09, 2015 - Impax Laboratories (IPXL) received clearance from the FDA for its manufacturing facility at Hayward, CA; shares jumped 12%.
Sep 04, 2015 - It has been a topsy-turvy ride for investors so far in 2015.
Sep 01, 2015 - Allergan (AGN) acquires central nervous system focused company, Naurex, to boost mental disorder portfolio.
Aug 28, 2015 - AxoGen (AXGN) was a big mover last session, with shares rising over 13% on the day.